National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 01:26:29

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65293-005-00	ML - Milliliter	65293-005	2e2e7f3c-3638-4f96-b2b1-0f505d133f5b	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
65293-005	65293-005-00

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N022156-001	CLEVIPREX	CLEVIDIPINE	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01
N022156-002	CLEVIPREX	CLEVIDIPINE	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01
N022156-003	CLEVIPREX	CLEVIDIPINE	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08

Orange Book patents#

Current patent rows page 1 of 1 · 9 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Coverage / status	Submission date
N022156-001	10010537	2031-10-10	Drug product	2018-07-12
N022156-001	11103490	2031-10-10	Drug product	2021-09-01
N022156-001	8658676	2031-10-10	Drug product	2014-03-06
N022156-002	10010537	2031-10-10	Drug product	2018-07-12
N022156-002	11103490	2031-10-10	Drug product	2021-09-01
N022156-002	8658676	2031-10-10	Drug product	2014-03-06
N022156-003	10010537	2031-10-10	Drug product	2018-07-12
N022156-003	11103490	2031-10-10	Drug product	2021-09-01
N022156-003	8658676	2031-10-10	Drug product	2014-03-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 132 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022156-002	CLEVIPREX	50MG/100ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022156-003	CLEVIPREX	125MG/250ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD	2013-11-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022156-001	CLEVIPREX	25MG/50ML (0.5MG/ML)	EMULSION / INTRAVENOUS	RLD, RS	2008-08-01	`79d66fd596c7…`

Observed Orange Book patent history#

Patent history page 1 of 10 · 399 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-10-15 13:18:30	2026-09	N022156-001	10010537	2031-10-10	Drug product	2018-07-12	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-001	11103490	2031-10-10	Drug product	2021-09-01	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-001	8658676	2031-10-10	Drug product	2014-03-06	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-002	10010537	2031-10-10	Drug product	2018-07-12	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-002	11103490	2031-10-10	Drug product	2021-09-01	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-002	8658676	2031-10-10	Drug product	2014-03-06	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-003	10010537	2031-10-10	Drug product	2018-07-12	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-003	11103490	2031-10-10	Drug product	2021-09-01	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022156-003	8658676	2031-10-10	Drug product	2014-03-06	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N022156-001	10010537	2031-10-10	Drug product	2018-07-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-001	11103490	2031-10-10	Drug product	2021-09-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-001	8658676	2031-10-10	Drug product	2014-03-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-002	10010537	2031-10-10	Drug product	2018-07-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-002	11103490	2031-10-10	Drug product	2021-09-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-002	8658676	2031-10-10	Drug product	2014-03-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-003	10010537	2031-10-10	Drug product	2018-07-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-003	11103490	2031-10-10	Drug product	2021-09-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022156-003	8658676	2031-10-10	Drug product	2014-03-06	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022156-001	10010537	2031-10-10	Drug product	2018-07-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-001	11103490	2031-10-10	Drug product	2021-09-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-001	8658676	2031-10-10	Drug product	2014-03-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-002	10010537	2031-10-10	Drug product	2018-07-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-002	11103490	2031-10-10	Drug product	2021-09-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-002	8658676	2031-10-10	Drug product	2014-03-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-003	10010537	2031-10-10	Drug product	2018-07-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-003	11103490	2031-10-10	Drug product	2021-09-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022156-003	8658676	2031-10-10	Drug product	2014-03-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022156-001	10010537	2031-10-10	Drug product	2018-07-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-001	11103490	2031-10-10	Drug product	2021-09-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-001	8658676	2031-10-10	Drug product	2014-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-002	10010537	2031-10-10	Drug product	2018-07-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-002	11103490	2031-10-10	Drug product	2021-09-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-002	8658676	2031-10-10	Drug product	2014-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-003	10010537	2031-10-10	Drug product	2018-07-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-003	11103490	2031-10-10	Drug product	2021-09-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022156-003	8658676	2031-10-10	Drug product	2014-03-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022156-001	10010537	2031-10-10	Drug product	2018-07-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022156-001	11103490	2031-10-10	Drug product	2021-09-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022156-001	8658676	2031-10-10	Drug product	2014-03-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022156-002	10010537	2031-10-10	Drug product	2018-07-12	`31067a03dcf5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.